JAMA Neurology : β-Blocker Use and Delayed Onset and Progression of Huntington Disease

In this installment, Jordan L. Schultz, an Assistant Professor of Neurology and Psychiatry at the University of Iowa, discusses his research on β-blockers and their role in Huntington's disease. Schultz highlights how these medications might delay the disease's onset and progression. He explores findings showing that patients on β-blockers enjoy better clinical outcomes and lower motor diagnosis risks. The conversation also delves into the use of different types of β-blockers and their potential impact on psychiatric symptoms, calling for further research.